DBV DBV Technologies SA

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

Information Regarding the Total Number of Voting Rights and 

Total Number of Shares of the Company as of December 31, 2025

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 



Date



 		Total number of shares Total number of voting rights
12/31/2025



 		232,207,589



 		 



Total gross of voting rights:



232,207,589



 
 



Total net* of voting rights:



232,133,009



 

* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment



EN
05/01/2026

Underlying

DBVDBV Technologies SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DBV Technologies SA

 PRESS RELEASE
Free
DBV DBV Technologie...

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO ...

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF AMF Regulated InformationChâtillon, France, January 7, 2026 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with ODDO BHF. Under the liquidity contract between DBV Technologies and ODDO BHF, the following assets appeared on the liquidity account as of December 31, 2025: 74,580 DBV Technologies shares,€ 5...

January 7, 2026 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BH...

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF Informations RéglementéesChâtillon, France, le 7 janvier (22 h 00 CET) 2026 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique français, publie aujourd’hui le bilan semestriel de son contrat de liquidité avec ODDO BHF. Au titre du contrat de liquidité confié à ODDO BHF, portant sur les actions de la société DBV TECHNOLOGIES, à la date du 31 décembre 2025, les moyens suivants figuraient au compte...

January 7, 2026 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information Regarding the Total Number of Voting Rights and Total Numb...

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345  Date  Total number of shares Total number of voting rights12/31/2025 232,207,589  Total gross of voting rights: 232,207,589  Total net* of voting rights: 232,133,009  * Net total = total number of voting rights at...

January 5, 2026 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information relative au nombre total des droits de vote et d’actions c...

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025 Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345  Date  Nombre totald’actionscomposant le capital socialNombre totalde droits de vote31/12/2025 232.207.589  Total brut des droits de vote : 232.207.589  Total net* des droits de vote : 232.133.009  *Total net = nombre to...

January 5, 2026 1 EN
Free Trial
DBV DBV Technologie...

DBV Technologies SA: 1 director

A director at DBV Technologies SA sold/sold after exercising options 2,893,202 shares at 3.437EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...

DBV DBV TECHNOLOGIES SA
12/25/25 December 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch